Welcome to our dedicated page for Koninklijke Phil news (Ticker: PHG), a resource for investors and traders seeking the latest updates and insights on Koninklijke Phil stock.
Koninklijke Philips N.V. reports health technology developments across Diagnosis & Treatment, Connected Care and Personal Health. News from Royal Philips commonly covers order intake and comparable sales trends; product launches and regulatory clearances for imaging, image-guided therapy and AI software; and governance actions from its Annual General Meeting. Recent product themes include CT platforms such as Rembra and Spectral CT Verida, interventional guidance tools such as DeviceGuide and IntraSight Plus, and the Bridge Plus Occlusion Balloon for lead extraction procedures.
The company’s updates also address hospital monitoring, informatics, ultrasound, oral health and personal-care lines. Coverage reflects Philips’ role as a Netherlands-based global health technology company with securities traded on NYSE under PHG and on Euronext Amsterdam under PHIA.
Summary not available.
On March 25, 2021, Royal Philips (NYSE: PHG) announced the sale of its Domestic Appliances business to Hillhouse Capital for an enterprise value of approximately EUR 3.7 billion. Philips expects to receive around EUR 3 billion in cash proceeds after tax and transaction costs. Additionally, a 15-year brand license agreement will yield an estimated net present value of EUR 0.7 billion, leading to a total deal value of approximately EUR 4.4 billion. This business will be listed as a discontinued operation in Philips' financial statements starting Q1 2021.
Royal Philips (NYSE: PHG) has announced its 2021 Annual General Meeting of Shareholders (AGM) to be held on May 6, 2021. Key agenda items include the reappointment of Mr. Marnix van Ginneken and the appointment of Mrs. Chua Sock Koong and Mrs. Indra Nooyi to the Board. Shareholders can vote and follow the meeting via webcast due to COVID-19 safety measures. The full agenda and the Annual Report 2020 are available on Philips’ website.
Royal Philips, American College of Cardiology (ACC), and MedAxiom have announced a collaboration aimed at improving cardiovascular care. This partnership seeks to enhance clinical outcomes and operational efficiency by integrating guidelines and actionable data across various healthcare stakeholders. Cardiovascular disease, a leading global health challenge, is expected to incur direct medical costs of $749 billion by 2035 in the U.S. The collaboration will utilize Philips' expertise and ACC's extensive resources to address these challenges and improve overall patient care.
Summary not available.
On March 9, 2021, Royal Philips announced a partnership with openDoctor to enhance its Patient Management Solution by integrating real-time online appointment scheduling. This customized solution aims to minimize appointment no-shows, enhance scheduling convenience, and improve patient satisfaction. Philips' platform has shown significant efficiency improvements, including a 30% rise in referral conversions and a 45% reduction in no-shows. The collaboration seeks to modernize patient engagement processes, benefiting both healthcare providers and patients amidst rising interest in digital health solutions.
Philips Avent launched the Double Electric Breast Pump, Advanced, featuring innovative Natural Motion Technology that simulates a baby's suckling for quicker milk flow. The pump's compact design accommodates busy mothers, offering hands-free use with a rechargeable battery and travel bag for portability. It includes 8 stimulation and 16 expression levels, with a memory function for personalized settings. Priced at $269.99, it is available on Philips.com with widespread retail availability forthcoming.
Royal Philips (NYSE: PHG) has launched the AI-enabled Precise Suite on its Incisive CT platform to enhance CT workflows. This suite integrates features like AI-driven image reconstruction and automated patient positioning, aiming to improve image quality and operational efficiency. It addresses challenges faced by radiology departments, such as rising patient volumes and operational costs. The suite is designed to boost diagnostic confidence, reduce the need for re-scans, and streamline interventional procedures, making it a significant advancement in health technology.
Royal Philips (NYSE: PHG) has announced a significant partnership with AI software provider Lunit to integrate its INSIGHT CXR chest detection suite into Philips’ diagnostic X-ray suite. This collaboration aims to enhance workflows and patient care through AI-enabled solutions presented at the European Congress of Radiology (ECR) 2021. Additionally, Philips' Digital Radiography and Fluoroscopy system (CombiDiagnost R90) has received FDA 510(k) clearance, improving cost-effective utilization in imaging departments. This comprehensive strategy reinforces Philips’ commitment to precision diagnosis and AI integration in healthcare.
On March 3, 2021, Royal Philips (NYSE: PHG) and The Walt Disney Company EMEA announced a collaboration to enhance pediatric MRI experiences. They will pilot the Philips Ambient Experience in six European hospitals, integrating custom Disney animations to alleviate children's anxiety during procedures. This first-of-its-kind clinical research aims to improve patient experiences and operational efficiency in MRI scanning by utilizing Disney's storytelling to create a relaxing atmosphere. The pilot will begin in summer 2021 with results expected later this year.